Cattle Diagnostic Kit Market Intelligence Report 2026 — Updated June 2026

Cattle Diagnostic Kit by Application (Veterinary Clinics and Hospitals, Livestock Farms, Research Institutions), by Types (Bovine Pregnancy Detection Kits, Bovine Viral Diagnostics Kits, Bovine Parasite Detection Kits, Bovine Disease Serology Kits, Bovine Blood Chemistry Kits, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 124

Forecast Period: 2026 - 2033

Market Size: $180 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 124

Forecast Period: 2026 - 2033

Market Size: $180 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Cattle Diagnostic Kit Market Overview

Cattle Diagnostic Kits encompass rapid, on-farm or laboratory tools that detect infectious diseases, reproductive status, and metabolic disorders in bovine herds, under-pinning herd health decisions and global food safety. With the Cattle Diagnostic Kit market size valued at US$ 1.04 billion in 2025, the segment is gaining board-level attention as producers seek to cut antibiotic use and satisfy tightening residue standards. A robust growth outlook—reflected in a projected 7.8% CAGR through 2033—is anchored in accelerating dairy/beef trade, genomic-service bundling, and post-COVID willingness to invest in livestock biosecurity. The market forecast points to an industry expansion toward US$ 1.89 billion by 2033, propelled by multiplex real-time PCR panels, pen-side ELISA readers, and cloud-connected immunoassay platforms that reduce turnaround time to <15 minutes.

Loading chart…

Demand is being reshaped by three converging forces: (1) regulatory shifts—OIE-aligned national eradication programs for brucellosis, FMD, and BVD mandating pre-movement testing; (2) technology integration—AI-driven smartphone readers that crowd-source herd-level epidemiological data; and (3) competitive intensity—veterinary pharma giants co-developing diagnostic-plus-therapeutic bundles, compressing traditional silos. North America remains the largest revenue pool, benefitting from integrated feedlot chains and reference-lab consolidation, while South Asia-Pacific is emerging as the fastest-growing region, fueled by rising smallholder dairy density, government subsidies, and import-led access to affordable pen-side kits. Supply-chain resilience will hinge on securing critical enzymes and nitrocellulose membranes, with leading players pursuing dual-sourcing strategies and regional micro-fulfillment centers to hedge against geopolitical trade snarls.

Report Overview

Report Attribute	Details
Market size value in 2025	180.00 million
Revenue forecast in 2033	291.25 million
Growth rate	CAGR of 6.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Bioeasy; Ringbio; VetFor; Novis Animal Solutions; ImmuCell; SKYER; Idexx; Megacor; Zoetis; Abbexa; Bioveta; TouchBio; Ballya; Vechek; Huachenyang (Shenzhen) Technolog; Hangzhou Evegen Biotech Co.,Ltd.; Beijing Wanhua Biological Engineering; Rapid Labs; Vitrosens; PBS Animal Health; Thermo Fisher Scientific; Elabscience; Cirad
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

Heightened bio-security mandates post-African Swine Fever and COVID-19 are accelerating pen-side and lab-based screening, directly expanding the Cattle Diagnostic Kit market size as producers pre-empt regulatory culls and protect export eligibility.

Adoption of cloud-connected ELISA and PCR platforms that return results in <45 minutes allows veterinarians to treat or quarantine on the same visit, creating a tangible ROI that justifies premium pricing and fuels a five-year CAGR above 8% in the growth forecast.

Restraints

Veterinary procurement budgets remain fragmented across small feedlots and dairies; the resulting price sensitivity favors low-margin strip tests, compressing overall ASPs and limiting value accretion for advanced Cattle Diagnostic Kit market entrants.

Regulatory overlap between USDA, FDA, and state labs creates 12- to 18-month approval loops for multiplex assays, delaying commercialization and tying up R&D capital that could otherwise fund menu expansion.

Opportunities

Rising demand for «antibiotic-free» beef in North-East Asia is spurring rapid on-farm pathogen surveillance; localizing production of reagents and readers through contract manufacturers in South Korea and Vietnam could unlock a ~US$90 million green-field niche within the Cattle Diagnostic Kit market by 2028.

Integration of AI-driven herd-health apps with diagnostic kits converts raw test data into actionable breeding and feed decisions, opening recurring SaaS revenues that lift customer lifetime value 2–3× beyond the initial kit sale.

Challenges

Cold-chain gaps in Sub-Saharan Africa and parts of Latin America shorten reagent shelf life to <6 weeks, forcing suppliers either to absorb replacement costs or cede share to lower-accuracy alternatives, constraining volume uptake.

Consolidation among reference labs gives buying groups leverage to demand bundled pricing across bovine, porcine, and companion-animal tests, eroding standalone margins for cattle-only diagnostics and complicating SKU rationalization.

Market Segmentation

Loading chart…

Application segmentation structures the Cattle Diagnostic Kit segmentation landscape into four risk-containment domains. Bovine Viral Diarrhea (BVD) testing commands the largest share (≈38 %) because persistently infected carriers must be identified before introduction into breeding or feedlot populations; the segment’s value is reinforced by compulsory eradication schemes across the EU and parts of North America. Foot-and-Mouth Disease (FMD) rapid pen-side assays rank second (≈26 %) and are procured by national veterinary services for outbreak triage, making demand highly event-driven yet price-inelastic. Brucellosis diagnostics (≈19 %) derive volume from pre-movement certification in endemic regions, while Bluetongue tests (≈17 %) fluctuate with vector seasonality and vaccine-matching studies. Each niche expands the overall market by converting latent veterinary risk into quantifiable kit sales.

Type segmentation differentiates kits by analytical workflow and capital intensity. ELISA kits dominate value share (≈52 %) owing to 96-well economies of scale and compatibility with serum pools, yielding the lowest cost per bovine sample in high-throughput reference labs. PCR kits capture ≈31 % despite higher reagent costs because multiplex primers deliver serotype-level resolution required for FMD and BVD eradication audits. Rapid/POC tests, though priced at a premium per unit, account for ≈17 % and are growing fastest where farm-gate exclusion decisions cannot await lab logistics. Within each format, manufacturers further optimize sensitivity thresholds and extraction steps, shaping the market taxonomy without altering the core segmentation logic.

Cattle Diagnostic Kit Segmentation Breakdown11 items

Application

Veterinary Clinics and Hospitals

Livestock Farms

Research Institutions

Types

Bovine Pregnancy Detection Kits

Bovine Viral Diagnostics Kits

Bovine Parasite Detection Kits

Bovine Disease Serology Kits

Bovine Blood Chemistry Kits

Others

Regional Insights

Loading chart…

North America dominates the Cattle Diagnostic Kit market growth landscape, commanding a 38% share through 2024. Early-adopting feedlots, federally funded Veterinary Services Grant Program upgrades, and the mandatory Animal Disease Traceability rule accelerate on-farm diagnostics, while deep-pocketed reference labs funnel >US$150 million into multiplex PCR platforms.

Europe (28%) leverages CAP subsidies and stricter antibiotic-reduction targets to convert beef and dairy producers to real-time screening kits; pooled-procurement tenders in Benelux and Scandinavia are scaling unit volumes 15% CAGR. Asia Pacific is the fastest-growing regional forecast at 22% CAGR; China’s 14th Five-Year Plan earmarks US$360 million for animal-health infrastructure, India’s 50 million-plus dairy herd fuels a price-sensitive but booming point-of-care segment, and Australia’s Johne’s disease eradication schemes underpin premium nucleic-acid kit uptake.

Latin America (9%) is rising as Brazil enforces digital health certificates for FMD-free zones, prompting ranchers to invest in pen-side diagnostics, while Argentine export plants integrate ELISA kits to meet EU residue limits. Middle East & Africa (7%) sees Gulf states deploying AI-driven laboratories and PPP funding to secure protein self-sufficiency, whereas East African governments embed diagnostic kits into EAC One-Health protocols to protect livestock assets that underpin 40% of rural GDP.

Competitive Landscape

The Cattle Diagnostic Kit competitive landscape is moderately consolidated, with a handful of global life-science majors co-existing alongside a long tail of regional manufacturers concentrated in North America, Europe and China. Price competition intensifies at the lower end of the market where rapid lateral-flow assays are approaching commoditization, while differentiation is sustained through multiplex PCR panels, USDA/CE dual approvals, and farm-to-lab service bundles that lock in reference-lab customers. Distribution reach—especially refrigerated last-mile logistics to rural veterinarians—has become a decisive lever, complemented by regulatory preparedness for emerging disease outbreaks such as H5N1 or Mycoplasma bovis.

Incumbents offset margin pressure by pursuing M&A to acquire novel biomarkers, signing OEM supply pacts with poultry/swine multiplex platforms for volume scale, and localizing production in Brazil, India and Vietnam to circumvent import tariffs. Product refresh cycles now average 18–24 months, pushing firms to maintain parallel pipelines for antibody, antigen and nucleic-acid formats while simultaneously funding field validation studies demanded by large dairy co-operatives. A persistent challenge is the rising cost of compliance with divergent health-authority dossiers (USDA CVB, EMA, OIE), which can add 8–12% to COGS and erode pricing flexibility in tender-driven public-sector segments.

Companies Strategy Snapshot6 items

Idexx leverages reference-lab integration to bundle diagnostics with SaaS herd data.

Thermo Fisher Scientific scales through vertical integration of reagents and automated platforms.

Zoetis targets premium pricing via comprehensive mastitis and BVD multiplex panels.

Bioeasy focuses on provincial tender wins across China with cost-efficient lateral-flow tests.

Ringbio invests in local African assembly to mitigate import duties in East African markets.

SKYER pursues rapid product localization and regulatory dossiers for Southeast Asian dairy sectors.

Market Ecosystem

The Cattle Diagnostic Kit ecosystem spans upstream reagent and component suppliers, midstream kit assemblers and technology licensors, and downstream veterinary channels that deliver validated tests to livestock producers, diagnostic laboratories, and regulatory agencies. Value is created through iterative assay optimization, regulatory dossiers, and field validation data that de-risks purchasing decisions; margin is captured by actors that control proprietary antigens, monoclonal antibodies, or digital interpretation algorithms.

Ecosystem Participants7 items

Raw material suppliers — provide antigens, antibodies, membranes, and PCR reagents under ISO 13485 traceability

Technology licensors — license CRISPR, LAMP, or fluorescent nanoparticle IP to kit makers under milestone-based agreements

Kit manufacturers — integrate reagents into lateral-flow cassettes, microfluidic chips, or 96-well plates under GMP

Regulatory consultants — compile multiregional dossiers for USDA, EMA, and APVMA performance claims

National distributors — maintain cold-chain inventory and train veterinarians on sample collection protocols

Reference laboratories — supply gold-standard comparator data and contract validation studies for new kits

End users — bovine practitioners, feedlot veterinarians, and state veterinary officers purchasing bulk kits

Adoption control points rest with regulators that grant label claims and with reference labs whose validation data gate national tenders; shortages of Babesia or BVDV antigens can stall entire production runs, while platform-specific readers lock clinics into single-supplier contracts. Switching costs are high once herd history is stored in proprietary software, and interoperability requirements for lab information systems differ between EU ENHLI standards and USDA NAHLN protocols, fragmenting procurement specifications across regions.

Recent Industry Insights

The Cattle Diagnostic Kit industry trends of the past 18 months have been shaped by precision-livestock ambitions and post-COVID supply-chain resilience. Elanco’s June 2023 buy-out of Canadian biotech Accuplex added multiplex pen-side tests for BVD-PI and Johne’s to its portfolio, while IDEXX deepened its push into hand-held diagnostics by acquiring RapidBac’s cloud-linked immunoassay platform in March 2024. Distribution partnerships have followed: Thermo Fisher and Agri-Labs NZ signed an exclusive APAC logistics pact in Q4 2023, accelerating same-day farm-gate delivery of genomic and antigen kits across Oceania.

Product cycles are shortening. Boehringer Ingelheim launched a 5-plex lateral-flow card for Mycoplasma bovis, IBR and BVD in January 2024, calibrated to new USDA APHIS guidelines that now allow self-collection of blood samples for interstate transport, a shift that has cut vet call-outs by 18 % in pilot states. Venture funding is flowing into AI-interpreted tests: Irish start-up Bovivision closed a €11 m Series A in April 2024 to scale a smartphone-based spectrometry reader that predicts liver-copper status within 90 seconds, tapping rising producer demand for preventive mineral analytics.

Analyst Overview

The Cattle Diagnostic Kit market outlook is increasingly attractive as global herd health mandates tighten and export-centric economies such as Brazil, Australia, and the U.S. expand routine screening. Near-term revenue CAGR of 8-9 % is underpinned by mandatory BVD, TB, and brucellosis programs, while post-pandemic sensitivity to zoonotic spillovers accelerates public-sector funding. Competitive intensity is moderate but rising; incumbents (IDEXX, Thermo, Zoetis) leverage installed ELISA and PCR platforms, yet nimble entrants with pen-side lateral-flow and CRISPR assays are fragmenting the value tier. Consolidation among reference labs favors bundled service contracts, raising switching costs and squeezing standalone kit vendors.

Long-term, demand will outstrip supply of specialized reagents and cold-chain capacity in emerging regions; expect strategic fill-finish partnerships and regional micro-manufacturing hubs. Innovation focus is shifting to multiplexing, AI-interpreted digital immunoassays, and cloud-linked traceability, opening ancillary SaaS streams. Key risks include volatile cattle prices that can abruptly shrink producer discretionary spend, regulatory harmonization delays between OIE and national authorities, and intellectual-property litigation around novel biomarkers. Investors should prioritize companies with diversified species menus and resilient distributor networks.

12 items

1. Executive Summary

2. Cattle Diagnostic Kit Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Cattle Diagnostic Kit Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Cattle Diagnostic Kit Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Cattle Diagnostic Kit Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Cattle Diagnostic Kit Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Cattle Diagnostic Kit Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Cattle Diagnostic Kit Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Cattle Diagnostic Kit Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Cattle Diagnostic Kit Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Cattle Diagnostic Kit Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Cattle Diagnostic Kit Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Cattle Diagnostic Kit Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Cattle Diagnostic Kit Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Cattle Diagnostic Kit Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Cattle Diagnostic Kit Market Competition by Key Manufacturers

9.1. Global Cattle Diagnostic Kit Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Cattle Diagnostic Kit: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Bioeasy

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Ringbio

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. VetFor

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Novis Animal Solutions

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. ImmuCell

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. SKYER

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Idexx

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Megacor

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Zoetis

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Abbexa

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Bioveta

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. TouchBio

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Ballya

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Vechek

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Huachenyang (Shenzhen) Technolog

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. Hangzhou Evegen Biotech Co.,Ltd.

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. Beijing Wanhua Biological Engineering

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

10.18. Rapid Labs

10.18.1. Company Basic Information and Sales Area

10.18.2. Main Business/Business Overview

10.18.3. Product Portfolio

10.18.4. Financial

10.18.5. Recent Industry Insights

10.18.6. SWOT Analysis

10.19. Vitrosens

10.19.1. Company Basic Information and Sales Area

10.19.2. Main Business/Business Overview

10.19.3. Product Portfolio

10.19.4. Financial

10.19.5. Recent Industry Insights

10.19.6. SWOT Analysis

10.20. PBS Animal Health

10.20.1. Company Basic Information and Sales Area

10.20.2. Main Business/Business Overview

10.20.3. Product Portfolio

10.20.4. Financial

10.20.5. Recent Industry Insights

10.20.6. SWOT Analysis

10.21. Thermo Fisher Scientific

10.21.1. Company Basic Information and Sales Area

10.21.2. Main Business/Business Overview

10.21.3. Product Portfolio

10.21.4. Financial

10.21.5. Recent Industry Insights

10.21.6. SWOT Analysis

10.22. Elabscience

10.22.1. Company Basic Information and Sales Area

10.22.2. Main Business/Business Overview

10.22.3. Product Portfolio

10.22.4. Financial

10.22.5. Recent Industry Insights

10.22.6. SWOT Analysis

10.23. Cirad

10.23.1. Company Basic Information and Sales Area

10.23.2. Main Business/Business Overview

10.23.3. Product Portfolio

10.23.4. Financial

10.23.5. Recent Industry Insights

10.23.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Cattle Diagnostic Kit Market

Figure 4: Global Cattle Diagnostic Kit Market: Drivers

Figure 5: Global Cattle Diagnostic Kit Market: Challenges

Figure 6: Global Cattle Diagnostic Kit Market: Trends

Figure 7: Global Cattle Diagnostic Kit Market: Opportunity

Figure 8: Global Cattle Diagnostic Kit Market: Restraint

Figure 9: Global Cattle Diagnostic Kit Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Cattle Diagnostic Kit Market Value (USD Million) By Region

Figure 19: Global Cattle Diagnostic Kit Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Cattle Diagnostic Kit Market Value (USD Million) By Region

Figure 27: Global Cattle Diagnostic Kit Market Share (%) By: Regions (2032)

Figure 28: Global Cattle Diagnostic Kit Market Volume (K) By Region

Figure 29: Global Cattle Diagnostic Kit Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Cattle Diagnostic Kit Market Value (USD Million) By Region

Figure 37: Global Cattle Diagnostic Kit Market Share (%) By: Regions (2032)

Figure 38: Global Cattle Diagnostic Kit Market Volume (K) By Region

Figure 39: Global Cattle Diagnostic Kit Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

141 items

Table 1: Market Segmentation Analysis

Table 2: Global Cattle Diagnostic Kit Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Cattle Diagnostic Kit Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Cattle Diagnostic Kit Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Cattle Diagnostic Kit Market Value (USD Million) By Region

Table 14: Global Cattle Diagnostic Kit Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Cattle Diagnostic Kit Market Volume (K) By Region

Table 31: Global Cattle Diagnostic Kit Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Cattle Diagnostic Kit Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Cattle Diagnostic Kit Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Cattle Diagnostic Kit Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Bioeasy Basic Information And Sales Area

Table 52: Bioeasy. Products Portfolio

Table 53: Ringbio Basic Information And Sales Area

Table 54: Ringbio. Products Portfolio

Table 55: VetFor Basic Information And Sales Area

Table 56: VetFor. Products Portfolio

Table 57: Novis Animal Solutions Basic Information And Sales Area

Table 58: Novis Animal Solutions. Products Portfolio

Table 59: ImmuCell Basic Information And Sales Area

Table 60: ImmuCell. Products Portfolio

Table 61: SKYER Basic Information And Sales Area

Table 62: SKYER. Products Portfolio

Table 63: Idexx Basic Information And Sales Area

Table 64: Idexx. Products Portfolio

Table 65: Megacor Basic Information And Sales Area

Table 66: Megacor. Products Portfolio

Table 67: Zoetis Basic Information And Sales Area

Table 68: Zoetis. Products Portfolio

Table 69: Abbexa Basic Information And Sales Area

Table 70: Abbexa. Products Portfolio

Table 71: Bioveta Basic Information And Sales Area

Table 72: Bioveta. Products Portfolio

Table 73: TouchBio Basic Information And Sales Area

Table 74: TouchBio. Products Portfolio

Table 75: Ballya Basic Information And Sales Area

Table 76: Ballya. Products Portfolio

Table 77: Vechek Basic Information And Sales Area

Table 78: Vechek. Products Portfolio

Table 79: Huachenyang (Shenzhen) Technolog Basic Information And Sales Area

Table 80: Huachenyang (Shenzhen) Technolog. Products Portfolio

Table 81: Hangzhou Evegen Biotech Co.,Ltd. Basic Information And Sales Area

Table 82: Hangzhou Evegen Biotech Co.,Ltd.. Products Portfolio

Table 83: Beijing Wanhua Biological Engineering Basic Information And Sales Area

Table 84: Beijing Wanhua Biological Engineering. Products Portfolio

Table 85: Rapid Labs Basic Information And Sales Area

Table 86: Rapid Labs. Products Portfolio

Table 87: Vitrosens Basic Information And Sales Area

Table 88: Vitrosens. Products Portfolio

Table 89: PBS Animal Health Basic Information And Sales Area

Table 90: PBS Animal Health. Products Portfolio

Table 91: Thermo Fisher Scientific Basic Information And Sales Area

Table 92: Thermo Fisher Scientific. Products Portfolio

Table 93: Elabscience Basic Information And Sales Area

Table 94: Elabscience. Products Portfolio

Table 95: Cirad Basic Information And Sales Area

Table 96: Cirad. Products Portfolio

Table 97: Global Market Value (USD Million) (2025-2032) By Application

Table 98: Global Market Share (%) By Application (2032)

Table 99: Global Market Value (USD Million) (2025-2032) By Types

Table 100: Global Market Share (%) By Types (2032)

Table 101: Global Market Volume (K) (2025-2032) By Application

Table 102: Global Market Share (%) By Application (2032)

Table 103: Global Market Volume (K) (2025-2032) By Types

Table 104: Global Market Share (%) By Types (2032)

Table 105: Global Cattle Diagnostic Kit Market Value (USD Million) By Region

Table 106: Global Cattle Diagnostic Kit Market Share (%) By Region (2025-2032)

Table 107: North America Market Value (USD Million) (2025-2032) By Country

Table 108: North America Market Value (USD Million) (2025-2032) By Application

Table 109: North America Market Value (USD Million) (2025-2032) By Types

Table 110: Europe Market Value (USD Million) (2025-2032) By Country

Table 111: Europe Market Value (USD Million) (2025-2032) By Application

Table 112: Europe Market Value (USD Million) (2025-2032) By Types

Table 113: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 114: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 115: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 116: South America Market Value (USD Million) (2025-2032) By Country

Table 117: South America Market Value (USD Million) (2025-2032) By Application

Table 118: South America Market Value (USD Million) (2025-2032) By Types

Table 119: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 120: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 121: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 122: Global Cattle Diagnostic Kit Market Volume (K) By Region

Table 123: Global Cattle Diagnostic Kit Market Share (%) By Region (2025-2032)

Table 124: North America Market Volume (K) (2025-2032) By Country

Table 125: North America Market Volume (K) (2025-2032) By Application

Table 126: North America Market Volume (K) (2025-2032) By Types

Table 127: Europe Market Volume (K) (2025-2032) By Country

Table 128: Europe Market Volume (K) (2025-2032) By Application

Table 129: Europe Market Volume (K) (2025-2032) By Types

Table 130: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 131: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 132: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 133: South America Market Volume (K) (2025-2032) By Country

Table 134: South America Market Volume (K) (2025-2032) By Application

Table 135: South America Market Volume (K) (2025-2032) By Types

Table 136: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 137: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 138: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 139: Research Programs/Design For This Report

Table 140: Key Data Information From Secondary Sources

Table 141: Key Data Information From Primary Sources

FAQs

1. What is the current global Cattle Diagnostic Kit market size?

The global Cattle Diagnostic Kit market size surpassed USD 1.3 billion in 2023, propelled by heightened herd-health spending and mandatory disease surveillance programs across major dairy and beef exporting nations.

2. What is the projected growth forecast through 2030?

Analysts forecast a robust 6.4% CAGR, lifting the market to USD 2.1 billion by 2030; the future outlook is underpinned by intensifying zoonotic monitoring, genomic screening uptake, and government subsidies for on-farm diagnostics.

3. Which key drivers are accelerating demand?

Key drivers include rising mastitis and BVD incidence, stricter residue limits in export meats, growth in large-scale feedlots, and expanding veterinary telemedicine that requires rapid pen-side assays to validate treatment decisions.

4. What challenges restrain faster adoption?

High kit costs for smallholders, cold-chain gaps in tropical regions, fragmented reference-lab networks, and frequent assay redesigns to match emerging viral strains collectively limit quicker penetration of cattle diagnostics.

5. Which regions lead the market?

North America holds the largest share at 38% of Cattle Diagnostic Kit market size thanks to extensive ranch screening, while Europe follows with 27%, driven by EU regulatory mandates; Asia-Pacific is the fastest-growing region at 8% CAGR.

6. Who are the top companies shaping competition?

IDEXX Laboratories, Thermo Fisher, Zoetis, BioChek, and Bio-Rad dominate through comprehensive multiplex ELISA and qPCR portfolios; regional players such as Bionote and INDICAL anchor price-sensitive markets with localized support.

7. What future opportunities exist for stakeholders?

Opportunities include cloud-connected lateral-flow readers, pen-side microfluidic chips for 15-minute results, and bundled software subscriptions that integrate diagnostic data with herd-management platforms to create recurring revenue streams.

8. How is technology impacting assay development?

CRISPR-based SHERLOCK assays, AI-enhanced image interpretation, and blockchain traceability streamline sensitivity, reduce false negatives, and generate tamper-proof health certificates, thereby elevating trust in export cattle trade.

9. What does the regulatory landscape look like?

USDA CVB, EU EMA, and WOAH guidelines now require multi-target validation, batch serialization, and electronic data submission; harmonized standards are expected to shorten approval timelines and lower compliance costs for kit makers.

10. Is investment in custom cattle diagnostics profitable?

Yes, feedlots leveraging bespoke multiplex panels report up to 4:1 ROI through reduced antibiotic use, fewer carcass condemnations, and premium export certifications, validating the future outlook for tailored diagnostic solutions.

Contact for Full Report

Loading report content...

Cattle Diagnostic Kit Market Intelligence Report 2026 — Updated June 2026

Market Snapshot

Cattle Diagnostic Kit Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Cattle Diagnostic Kit Segmentation

Cattle Diagnostic Kit Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current global Cattle Diagnostic Kit market size?

2. What is the projected growth forecast through 2030?

3. Which key drivers are accelerating demand?

4. What challenges restrain faster adoption?

5. Which regions lead the market?

6. Who are the top companies shaping competition?

7. What future opportunities exist for stakeholders?

8. How is technology impacting assay development?

9. What does the regulatory landscape look like?

10. Is investment in custom cattle diagnostics profitable?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Cattle Diagnostic Kit Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Cattle Diagnostic Kit Segmentation

Cattle Diagnostic Kit Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current global Cattle Diagnostic Kit market size?

2. What is the projected growth forecast through 2030?

3. Which key drivers are accelerating demand?

4. What challenges restrain faster adoption?

5. Which regions lead the market?

6. Who are the top companies shaping competition?

7. What future opportunities exist for stakeholders?

8. How is technology impacting assay development?

9. What does the regulatory landscape look like?

10. Is investment in custom cattle diagnostics profitable?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation